Novelion Therapeutics Inc. (NVLN) Rose 8.26% or 0.29 To Price $3.8 On Thursday


Novelion Therapeutics Inc. (NVLN) rose 8.26% or 0.29 to $3.8. It is close to 67336 shares traded, which is 63.52% compare to the average total volume 106014. The market cap of NVLN is $70.52 million. The year to date change is 5.41%. The 52 week price range is from $3.08 to $12.12. Price of NVLN have changed 8.00% during last week. It have changed -7.39% over last month, -51.05% over last 3 months, -62.54% over last 6 months and -57.30% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVLN is 4.20. It is 10.53% above current price. The 200-day Moving Averages for NVLN is 7.63. It is 100.79% above current price. The 52-week High is 12.12. It is 218.95% from the current price. The 52-week Low is 3.08. It is -18.95% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NVLN is 16.4 on 2017-12-15. Short % to float is 11.31%. There are some statistics of NVLN. It is has market cap $70.52 million. The share outstanding is 18.56 million. The average volume is 106014. The percent of top 15 Institution holding is 81.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVLN is -216.13%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVLN is -50.09%.


Tags:

Share this post